Current Status of Plant-Based Bioactive Compounds as Therapeutics in Alzheimer’s Diseases

Current Status of Plant-Based Bioactive Compounds as Therapeutics in Alzheimer’s Diseases

Alzheimer’s disease (AD) is a common central neurodegenerative disease disorder characterized primarily by cognitive impairment and non-cognitive neuropsychiatric symptoms that significantly impact patients’ daily lives and behavioral functioning. The pathogenesis of AD remains unclear and current W...

Full description

Saved in:

Bibliographic Details
Main Authors:	Dan Chen, Yun Sun
Format:	Article
Language:	English
Published:	IMR Press 2025-01-01
Series:	Journal of Integrative Neuroscience
Subjects:	alzheimer’s disease medicinal plants neuroprotection cognitive function neuroinflammation
Online Access:	https://www.imrpress.com/journal/JIN/24/1/10.31083/JIN23090
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Insufficient Sleep and Alzheimer’s Disease: Potential Approach for Therapeutic Treatment Methods
by: Dieu Quynh Trinh, et al.
Published: (2024-12-01)

Medicinal plants with neuroprotective potential in East African countries: A systematic review
by: Ibe Michael Usman, et al.
Published: (2025-02-01)

Isoforsythiaside confers neuroprotection against Alzheimer’s disease by attenuating ferroptosis and neuroinflammation in vivo and in vitro
by: Chunyue Wang, et al.
Published: (2023-09-01)

Evolution of Alzheimer’s Disease Therapeutics: From Conventional Drugs to Medicinal Plants, Immunotherapy, Microbiotherapy and Nanotherapy
by: Emma Ortiz-Islas, et al.
Published: (2025-01-01)

The antioxidant potential of bacoside and its derivatives in Alzheimer's disease: The molecular mechanistic paths and therapeutic prospects
by: Dipanjan Karati, et al.
Published: (2025-06-01)

Brain targeting based nanocarriers loaded with resveratrol in Alzheimer's disease: A review
by: Cyrus Jalili, et al.
Published: (2023-05-01)

Delta-opioid receptor signaling alleviates neuropathology and cognitive impairment in the mouse model of Alzheimer’s disease by regulating microglia homeostasis and inhibiting HMGB1 pathway
by: Yuan Xu, et al.
Published: (2025-02-01)

Lipid mediators in post-mortem brain samples from patients with Alzheimer's disease: A systematic review
by: Aidan D. Tyrrell, et al.
Published: (2025-02-01)

Fighting Alzheimer’s with Movement: The Role of Physical Activity in Disease Management
by: Agnieszka Kosińska, et al.
Published: (2025-02-01)

Editorial: 15 years of Frontiers in Cellular Neuroscience: the dual role of microglia in (neuro)inflammation
by: Antonio J. Herrera, et al.
Published: (2025-02-01)

Deciphering the Role of Adrenergic Receptors in Alzheimer’s Disease: Paving the Way for Innovative Therapies
by: Androulla N. Miliotou, et al.
Published: (2025-01-01)

A Network Pharmacology Study and Experimental Validation to Identify the Potential Mechanism of Heparan Sulfate on Alzheimer’s Disease-Related Neuroinflammation
by: Dong-Uk Kim, et al.
Published: (2025-01-01)

Neuroprotective role of epigallocatechin-3-gallate, albeginin and melanoxetin in alzheimer's disease
by: Arif Malik, et al.
Published: (2025-02-01)

Multifaceted neuroprotective effects of (-)-epigallocatechin-3-gallate (EGCG) in Alzheimer’s disease: an overview of pre-clinical studies focused on β-amyloid peptide
by: Kumju Youn, et al.
Published: (2022-05-01)

GENI as an AMPK Activator Binds α and γ Subunits and Improves the Memory Dysfunction of Alzheimer’s Disease Mouse Models via Autophagy and Neuroprotection
by: Ying Wang, et al.
Published: (2025-01-01)

C/EBPβ in Alzheimer’s disease: An integrative regulator of pathological mechanisms
by: Xiaoting Luo, et al.
Published: (2025-02-01)

Iron Homeostasis Dysregulation, Oro-Gastrointestinal Microbial Inflammatory Factors, and Alzheimer’s Disease: A Narrative Review
by: Agata Kuziak, et al.
Published: (2025-01-01)

Molecular Mechanisms Underlying Neuroinflammation Intervention with Medicinal Plants: A Critical and Narrative Review of the Current Literature
by: Sandra Maria Barbalho, et al.
Published: (2025-01-01)

Postnatal expression of Cat-315-positive perineuronal nets in the SAMP10 mouse primary somatosensory cortex
by: Hiroshi Ueno, et al.
Published: (2025-06-01)

Diabetes-related cognitive impairment: Mechanisms, symptoms, and treatments
by: Yu Xueting, et al.
Published: (2025-01-01)

Citrulline – The Powerhouse Nutrient for Cardiometabolic and Brain Health
by: Daria Pedrycz, et al.
Published: (2025-02-01)

Molecular Mechanisms of Alzheimer’s Disease Induced by Amyloid-β and Tau Phosphorylation Along with RhoA Activity: Perspective of RhoA/Rho-Associated Protein Kinase Inhibitors for Neuronal Therapy
by: Eun Hee Ahn, et al.
Published: (2025-01-01)

The Role of Air Pollution and Olfactory Dysfunction in Alzheimer’s Disease Pathogenesis
by: Louise Odendaal, et al.
Published: (2025-01-01)

Exploring the effects of combined nostalgic activities and music therapy on Alzheimer's disease outcomes
by: Yunqiu Zhang, et al.
Published: (2025-01-01)

Assessment of the Impact of Different Types and Intensities of Physical Exercise on the Quality of Life of Patients with Alzheimer’s Disease: A Literature Review
by: Katarzyna Barabasz, et al.
Published: (2025-01-01)

CD22 modulation alleviates amyloid β-induced neuroinflammation
by: Yu Dong Mai, et al.
Published: (2025-02-01)

Toward a new interdisciplinary model to understand Alzheimer’s disease: The interplay between neurobiology and socio-economic factors
by: Hyun Jee Han, et al.
Published: (2018-11-01)

Bioactive compounds from Chinese herbal plants for neurological health: mechanisms, pathways, and functional food applications
by: Wang Meng, et al.
Published: (2025-01-01)

Incidence and Prevalence of Alzheimer’s Disease in Medicare Beneficiaries
by: Haixin Zhang, et al.
Published: (2024-12-01)

Diagnosis and Treatment of Alzheimer’s Disease: Current Update
by: Younghee Yim, et al.
Published: (2025-01-01)

A systematic review and meta-analysis of the impact of transcranial direct current stimulation on cognitive function in older adults with cognitive impairments: the influence of dosage parameters
by: Thatchaya Prathum, et al.
Published: (2025-02-01)

Network pharmacology and experimental verification to investigate the mechanism of isoliquiritigenin for the treatment of Alzheimer’s disease
by: Waimao Gao, et al.
Published: (2025-02-01)

Natural bioactive compounds form herbal medicine in Alzheimer’s disease: from the perspective of GSK-3β
by: Mei Wang, et al.
Published: (2025-02-01)

Targeting early tau pathology: probiotic diet enhances cognitive function and reduces inflammation in a preclinical Alzheimer’s model
by: Cassandra M. Flynn, et al.
Published: (2025-01-01)

Multi-omics analyses identify gut microbiota-fecal metabolites-brain-cognition pathways in the Alzheimer’s disease continuum
by: Han Zhao, et al.
Published: (2025-02-01)

Alzheimer’s disease may develop from changes in the immune system, cell cycle, and protein processing following alterations in ribosome function
by: Akiko Yamakawa, et al.
Published: (2025-01-01)

Neurogranin in Alzheimer's Disease: Roles in synaptic function, pathology, and potential as a diagnostic biomarker
by: Rajkumar Bavaharini, et al.
Published: (2024-09-01)

Rethinking the residual approach: leveraging statistical learning to operationalize cognitive resilience in Alzheimer’s disease
by: Colin Birkenbihl, et al.
Published: (2025-01-01)

Heterogeneous clinical phenotypes of sporadic early-onset Alzheimer’s disease: a neuropsychological data-driven approach
by: Deepti Putcha, et al.
Published: (2025-02-01)

Lipidome disruption in Alzheimer’s disease brain: detection, pathological mechanisms, and therapeutic implications
by: Sijia He, et al.
Published: (2025-01-01)